Yaya Chu

819 total citations
50 papers, 635 citations indexed

About

Yaya Chu is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Yaya Chu has authored 50 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 34 papers in Immunology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Yaya Chu's work include CAR-T cell therapy research (33 papers), Immune Cell Function and Interaction (33 papers) and Lymphoma Diagnosis and Treatment (12 papers). Yaya Chu is often cited by papers focused on CAR-T cell therapy research (33 papers), Immune Cell Function and Interaction (33 papers) and Lymphoma Diagnosis and Treatment (12 papers). Yaya Chu collaborates with scholars based in United States, China and Switzerland. Yaya Chu's co-authors include Mitchell S. Cairo, Gaurav Nayyar, Janet Ayello, Matthew J. Barth, Carmella van de Ven, Jessica Hochberg, Myron S. Czuczman, Dean A. Lee, Brian Z. Huang and Jeremy Rosenblum and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Yaya Chu

47 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaya Chu United States	13	463	431	131	92	72	50	635
Sunil S. Raikar United States	13	405 0.9×	252 0.6×	205 1.6×	55 0.6×	111 1.5×	37	639
Erik F. Williams United States	3	388 0.8×	224 0.5×	170 1.3×	42 0.5×	76 1.1×	4	556
Dmitry Pankov United States	11	464 1.0×	344 0.8×	183 1.4×	35 0.4×	73 1.0×	17	620
Lisa Marie Serrano United States	8	459 1.0×	268 0.6×	116 0.9×	32 0.3×	169 2.3×	9	543
May Daher United States	16	631 1.4×	629 1.5×	275 2.1×	37 0.4×	102 1.4×	38	1.0k
Grit Lorenczewski Germany	13	746 1.6×	441 1.0×	269 2.1×	79 0.9×	43 0.6×	17	995
Melanie Märklin Germany	13	295 0.6×	364 0.8×	229 1.7×	35 0.4×	37 0.5×	49	686
Sabine Stienen Germany	13	491 1.1×	307 0.7×	148 1.1×	30 0.3×	46 0.6×	26	639
Marion Alcantara France	9	259 0.6×	121 0.3×	103 0.8×	145 1.6×	68 0.9×	24	402
Anna Capsomidis United Kingdom	5	381 0.8×	397 0.9×	129 1.0×	15 0.2×	85 1.2×	7	622

Countries citing papers authored by Yaya Chu

Since Specialization

Citations

This map shows the geographic impact of Yaya Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaya Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaya Chu more than expected).

Fields of papers citing papers by Yaya Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaya Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaya Chu. The network helps show where Yaya Chu may publish in the future.

Co-authorship network of co-authors of Yaya Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaya Chu. A scholar is included among the top collaborators of Yaya Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaya Chu. Yaya Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chu, Yaya, Gaurav Nayyar, Dean A. Lee, et al.. (2024). Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts. SHILAP Revista de lepidopterología. 32(2). 200820–200820. 2 indexed citations

Chu, Yaya, Uksha Saini, M. Fevzi Özkaynak, et al.. (2024). Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma. SHILAP Revista de lepidopterología. 33(1). 200927–200927. 5 indexed citations

Hai, Hoang, Yaya Chu, Yanling Liao, et al.. (2024). Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma. PubMed. 32(4). 200894–200894.

Hochberg, Jessica, Qiuhu Shi, Yaya Chu, et al.. (2024). Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812). Blood. 144(Supplement 1). 2515–2515. 1 indexed citations

Zhang, Xiaowei, et al.. (2024). Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection. Rheumatology and Therapy. 11(1). 191–200.

Chu, Yaya, Caroline Diorio, Lianna J. Marks, et al.. (2023). Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma. Best Practice & Research Clinical Haematology. 36(1). 101442–101442. 3 indexed citations

Zhu, Hongwen, Jian Pan, Wen Luo, et al.. (2023). Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin. Frontiers in Immunology. 14. 1211505–1211505. 11 indexed citations

Chu, Yaya, Julie‐An Talano, Lee Ann Baxter‐Lowe, et al.. (2022). Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease. Frontiers in Immunology. 13. 1055497–1055497. 1 indexed citations

Chu, Yaya, et al.. (2022). Optimizing Chimeric Antigen Receptor (CAR) Engineered NK Cell-Mediated Cytotoxicity Combined with Anti-CD20 or Anti-CD79 Therapeutic Antibodies and NKTR-255 in Burkitt Lymphoma (BL). Transplantation and Cellular Therapy. 28(3). S164–S165. 1 indexed citations

10.

Chu, Yaya, Gaurav Nayyar, Jeremy Rosenblum, et al.. (2021). Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2⁺ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice. Journal for ImmunoTherapy of Cancer. 9(7). e002267–e002267. 31 indexed citations

11.

Kararoudi, Meisam Naeimi, Brian P. Tullius, Nitin Chakravarti, et al.. (2020). Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity. Seminars in Hematology. 57(4). 201–212. 17 indexed citations

12.

Chu, Yaya, Gaurav Nayyar, Nang Kham Su, et al.. (2020). Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Journal for ImmunoTherapy of Cancer. 8(2). e001238–e001238. 11 indexed citations

13.

Chu, Yaya, et al.. (2019). Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma. British Journal of Haematology. 185(6). 1055–1070. 13 indexed citations

14.

Shereck, Evan, Nancy S. Day, Aradhana Awasthi, et al.. (2019). Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56^Dim NK cells. Innate Immunity. 25(5). 294–304. 8 indexed citations

15.

Nayyar, Gaurav, Yaya Chu, & Mitchell S. Cairo. (2019). Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors. Frontiers in Oncology. 9. 51–51. 132 indexed citations

16.

Chu, Yaya, Nang Kham Su, Sarah Alter, et al.. (2017). Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL). Blood. 130. 3587–3587. 1 indexed citations

17.

Chu, Yaya, Carl V. Hamby, Brian Hang, et al.. (2016). Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by ALT-803, an IL-15 superagonist. Experimental Hematology. 44(9). S64–S64. 1 indexed citations

18.

Ayello, Janet, Jessica Hochberg, Allyson Flower, et al.. (2016). Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy. Experimental Hematology. 46. 38–47. 17 indexed citations

19.

Chu, Yaya, Jessica Hochberg, Janet Ayello, et al.. (2014). Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice. Cancer Immunology Research. 3(4). 333–344. 143 indexed citations

20.

Satwani, Prakash, Aniket Saha, Frances Zhao, et al.. (2014). Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity. Cytotherapy. 16(10). 1431–1440. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact